Eagle Pharmaceuticals
BELRAPZO
Manufacturer:
Eagle Pharmaceuticals
Name:
BELRAPZO
HCPCS Code Descriptor:
Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg
Category:
J Code
HCPCS:
J9036
NDC(s):
42367-0521-25, 42367-0520-25, 60505-6228-00
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
BELRAPZO is an Oncology drug manufactured by Eagle Pharmaceuticals and administered via the Intravenous route of administration. The J Code: J9036 is aligned to the drug BELRAPZO.
Belrapzo is used to treat certain types of cancer and belongs to group of drugs known as alkylating agents. Belrapzo is manufactured by both Eagle Pharmaceuticals and Baxter Healthcare. There are two J Codes for Belrapzo: J9036 and J9306. Patient assistance programs for this medication can be found through Eagle Pharmaceuticals at the Eagle Can: Care & Access Network.